| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |